Abstract
Malignant neoplasms of the head and neck are among the most common in the world and constitute a major public health problem in most countries. Over 90 % of these are squamous cell carcinomas arising in the mucous membranes of the upper aerodigestive tract (UADT). Their epidemiology and aetiology are considered in detail. We separate nasopharyngeal cancer, because it has a specific aetiology related to Epstein–Barr virus (EBV) infection and dietary carcinogens. We then add those sites with the common major risk factors of alcohol, tobacco (including betel quid/areca nut habits), poor dentition and diets poor in antioxidants and vitamins and an increasingly recognised role for human papillomavirus (HPV). By simplistically adding age-standardised rates together, collectively these UADT sites of the oral cavity (including the tongue), nasopharynx, other pharynx and larynx have a male incidence/mortality of 14.3/7.9 and for females of 4.4/2.3 cases per 100,000 pa. This ranks UADT cancer as the sixth most common site for men and eighth for women across the world. If the oesophagus were to be included as another alcohol- and tobacco-related cancer, the rates add to 23.3/15.6 and 7.5/5.0, respectively. These cancers—which might be termed cancers of the mouth, pharynx, throat and gullet—then rank second only to lung cancer in men, and fourth after breast, uterine cervix and large bowel in females, worldwide.
Detailed data are presented on geographical, ethnic, gender and time differences. The highest rates in the world are found in Melanesia, South Asia, parts of France and much of Eastern Europe and the former Soviet republics. Whilst the rates are now trending downwards for the “traditional” alcohol- and tobacco-related cancers in much of the developed world, the numbers remain high and constitute a considerable personal and public health burden. Many areas are showing rising trends, particularly for oropharyngeal cancer, with a shift to involvement of younger individuals. This, and the fact that survival rates have improved little, except for the most sophisticated multidisciplinary treatment centres, emphasises the need for effective primary and secondary prevention strategies—and for improved public policy to implement these.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- EBV:
-
Epstein–Barr virus
- GATS:
-
Global Adult Tobacco Survey
- H&N:
-
Head and neck
- HHV:
-
Human herpesviruses
- HN:
-
Head and neck
- HO:
-
Hydroxyl radical
- HPV:
-
Human papillomavirus
- IARC:
-
International Agency for Research on Cancer
- IIPS:
-
International Institute for Population Sciences
- INHANCE:
-
International Head and Neck Cancer Epidemiology Consortium
- KS:
-
Kaposi sarcoma
- MNPN:
-
Methylnitrosaminoproprionitrile
- NNK:
-
Nicotine-derived nitrosamine ketone
- NNN:
-
Nitrosonornicotine
- NPC:
-
Nasopharyngeal cancer
- OPC:
-
Oropharyngeal cancer
- OPMD:
-
Oral potentially malignant disorders
- OSF:
-
Oral submucous fibrosis
- OSCC:
-
Oral squamous cell carcinoma
- PAH:
-
Polycyclic aromatic hydrocarbons
- PNG:
-
Papua New Guinea
- ROS:
-
Reactive oxygen species
- SCCs:
-
Squamous cell carcinomas
- SEER:
-
Surveillance, Epidemiology, and End Results program
- ST:
-
Smokeless or chewing tobacco
- TSNA:
-
Tobacco-specific nitrosamines
- UADT:
-
Upper aerodigestive tract
- WHO:
-
World Health Organisation
References
Johnson NW, Warnakulasuriya S, Gupta PC, et al. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res. 2011;23(2):237–46.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon: International Agency for Research on Cancer; 2013. Available from http://globocan.iarc.fr. Accessed 20 Nov 2014.
Forman D, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J, editors. Cancer incidence in five continents, Vol. X (electronic version). Lyon: IARC; 2013. http://ci5.iarc.fr. Accessed 22 Nov 2014.
Bhawna G. Burden of smoked and smokeless tobacco consumption in India – results from the Global Adult Tobacco Survey India (GATS-India) 2009–2010. Asian Pac J Cancer Prev. 2013;14(5):3323–9.
Sankaranarayanan R. Oral cancer in India: an epidemiologic and clinical review. Oral Surg Oral Med Oral Pathol. 1990;69(3):325–30.
World Health Organization. Control of oral cancer in developing countries. A WHO meeting. Bull WHO. 1984;62(6):817–30.
National Cancer Control Programme Sri Lanka. Cancer incidence data: Sri Lanka Year 2001–2005. Colombo: NCCP. 7th Publication 2009.
Ministry of Health Malaysia. Second report of the National Cancer Registry, Cancer incidence in Malaysia 2003. Available from http://www.radiologymalaysia.org/Archive/NCR/2ndNCR.pdf. Accessed 9 Dec 2009.
Satyanarayana L, Asthana S. Life time risk for development of ten major cancers in India and its trends over the years 1982 to 2000. Indian J Med Sci. 2008;62(2):35–44.
Gupta B, Ariyawardana A, Johnson NW. Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives. Int Dent J. 2013;63(1):12–25.
Gupta PC, Nandakumar A. Oral cancer scene in India. Oral Dis. 1999;5(1):1–2.
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96.
Moore SR, Allister J, Roder D, Pierce AM, Wilson DF. Lip cancer in South Australia, 1977–1996. Pathology. 2001;33(2):167–71.
Nemes JA, Redl P, Boda R, Kiss C, Marton IJ. Oral cancer report from Northeastern Hungary. Pathol Oncol Res. 2008;14(1):85–92.
Tanaka S, Sobue T. Comparison of oral and pharyngeal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960–2000). Jpn J Clin Oncol. 2005;35(8):488–91.
Bosetti C, Bertuccio P, Levi F, Lucchini F, Negri E, La Vecchia C. Cancer mortality in the European Union, 1970–2003, with a joinpoint analysis. Ann Oncol. 2008;19(4):631–40.
Brandizzi D, Chuchurru JA, Lanfranchi HE, Cabrini RL. Analysis of the epidemiological features of oral cancer in the city of Buenos Aires. Acta Odontol Latinoam. 2005;18(1):31–5.
Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44(10):1345–89.
Conway DI, Stockton DL, Warnakulasuriya KA, Ogden G, Macpherson LM. Incidence of oral and oropharyngeal cancer in United Kingdom (1990–1999) – recent trends and regional variation. Oral Oncol. 2006;42(6):586–92.
Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975–2011. Bethesda, MD: National Cancer Institute; 2014. http://seer.cancer.gov/csr/1975_2011/ based on November 2013 SEER data submission, posted to the SEER web site.
Suba Z. Gender-related hormonal risk factors for oral cancer. Pathol Oncol Res. 2007;13(3):195–202.
Liu L, Kumar SK, Sedghizadeh PP, Jayakar AN, Shuler CF. Oral squamous cell carcinoma incidence by subsite among diverse racial and ethnic populations in California. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(4):470–80.
Reichman ME, Kelly JJ, Kosary CL, Coughlin SS, Jim MA, Lanier AP. Incidence of cancers of the oral cavity and pharynx among American Indians and Alaska Natives, 1999–2004. Cancer. 2008;113(5 Suppl):1256–65.
Nichols AC, Bhattacharyya N. Racial differences in stage and survival in head and neck squamous cell carcinoma. Laryngoscope. 2007;117(5):770–5.
Gourin CG, Podolsky RH. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope. 2006;116(7):1093–106.
Suarez E, Calo WA, Hernandez EY, Diaz EC, Figueroa NR, Ortiz AP. Age-standardized incidence and mortality rates of oral and pharyngeal cancer in Puerto Rico and among Non-Hispanics Whites, Non-Hispanic Blacks, and Hispanics in the USA. BMC Cancer. 2009;9:129.
Moles DR, Fedele S, Speight PM, Porter SR, dos Santos Silva I. Oral and pharyngeal cancer in South Asians and non-South Asians in relation to socioeconomic deprivation in South East England. Br J Cancer. 2008;98(3):633–5.
Chhetri DK, Rawnsley JD, Calcaterra TC. Carcinoma of the buccal mucosa. Otolaryngol Head Neck Surg. 2000;123(5):566–71.
Diaz Jr EM, Holsinger FC, Zuniga ER, Roberts DB, Sorensen DM. Squamous cell carcinoma of the buccal mucosa: one institution's experience with 119 previously untreated patients. Head Neck. 2003;25(4):267–73.
Iyer SG, Pradhan SA, Pai PS, Patil S. Surgical treatment outcomes of localized squamous carcinoma of buccal mucosa. Head Neck. 2004;26(10):897–902.
Liao CT, Wang HM, Ng SH, et al. Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol. 2006;42(8):800–9.
Lin CS, Jen YM, Cheng MF, et al. Squamous cell carcinoma of the buccal mucosa: an aggressive cancer requiring multimodality treatment. Head Neck. 2006;28(2):150–7.
Sieczka E, Datta R, Singh A, et al. Cancer of the buccal mucosa: are margins and T-stage accurate predictors of local control? Am J Otolaryngol. 2001;22(6):395–9.
National Cancer Institute. Surveillance Epidemiology and End Results (SEER). SEER Cancer Statistic Review 1975–2004. Available from http://seer.cancer.gov/statfacts/html/oralcav.html. Accessed 8 Jan 2010.
Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people–a comprehensive literature review. Oral Oncol. 2001;37(5):401–18.
Warnakulasuriya S, Mak V, Moller H. Oral cancer survival in young people in South East England. Oral Oncol. 2007;43(10):982–6.
Macfarlane GJ, Boyle P, Scully C. Rising mortality from cancer of the tongue in young Scottish males. Lancet. 1987;2(8564):912.
Annertz K, Anderson H, Biorklund A, et al. Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer. 2002;101(1):95–9.
Schantz SP, Yu GP. Head and neck cancer incidence trends in young Americans, 1973–1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg. 2002;128(3):268–74.
Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20–44 years. Cancer. 2005;103(9):1843–9.
Scully C, Bedi R. Ethnicity and oral cancer. Lancet Oncol. 2000;1(1):37–42.
Robinson KL, Macfarlane GJ. Oropharyngeal cancer incidence and mortality in Scotland: are rates still increasing? Oral Oncol. 2003;39(1):31–6.
Elango JK, Gangadharan P, Sumithra S, Kuriakose MA. Trends of head and neck cancers in urban and rural India. Asian Pac J Cancer Prev. 2006;7(1):108–12.
Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med. 2004;33(9):525–32.
Hirota SK, Braga FP, Penha SS, Sugaya NN, Migliari DA. Risk factors for oral squamous cell carcinoma in young and older Brazilian patients: a comparative analysis. Med Oral Patol Oral Cir Bucal. 2008;13(4):E227–31.
World Health Organization. Mortality database. http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html. Accessed 26 Feb 2014.
La Vecchia C, Lucchini F, Negri E, Levi F. Trends in oral cancer mortality in Europe. Oral Oncol. 2004;40(4):433–9.
Morse DE, Kerr AR. Disparities in oral and pharyngeal cancer incidence, mortality and survival among black and white Americans. J Am Dent Assoc. 2006;137(2):203–12.
Moore RJ, Doherty DA, Do KA, Chamberlain RM, Khuri FR. Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx. Ethn Health. 2001;6(3–4):165–77.
Sunny L, Yeole BB, Hakama M, et al. Oral cancers in Mumbai, India: a fifteen years perspective with respect to incidence trend and cumulative risk. Asian Pac J Cancer Prev. 2004;5(3):294–300.
Gupta B, Johnson NW. Emerging and established global life-style risk factors for cancer of the upper aero-digestive tract. Asian Pac J Cancer Prev. 2014;15(15):5983–91.
Koo K, Barrowman R, McCullough M, Iseli T, Wiesenfeld D. Non-smoking non-drinking elderly females: a clinically distinct subgroup of oral squamous cell carcinoma patients. Int J Oral Maxillofac Surg. 2013;42(8):929–33.
Amarasinghe HK, Usgodaarachchi US, Johnson NW, Lalloo R, Warnakulasuriya S. Betel-quid chewing with or without tobacco is a major risk factor for oral potentially malignant disorders in Sri Lanka: a case-control study. Oral Oncol. 2010;46(4):297–301.
International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risk to humans: betel-quid and areca-nut chewing and some areca-nut related nitrosamines, vol. 85. Lyon: IARC; 2004. p. 1–334.
Secretan B, Straif K, Baan R, et al. A review of human carcinogens–Part E: Tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10(11):1033–4.
International Agency for Research on Cancer. A review of human carcinogens: personal habits and indoor combustion. Lyon: IARC; 2012. Monograph 100 Part E, 1–538.
Zaidi JH, Arif M, Fatima I, Qureshi IH. Radiochemical neutron activation analysis for trace elements of basic ingredients of pan. J Radioanal Nucl Chem. 2002;253:459–64.
Lee CH, Ko AM, Warnakulasuriya S, et al. Intercountry prevalences and practices of betel-quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by Asian betel-quid consortium of south and east Asia. Int J Cancer. 2011;129(7):1741–51.
WHO Library Cataloguing in Publication Data 2012. Review of areca (betel) nut and tobacco use in the Pacific: a technical report. World Health Organization Regional Office for the Western Pacific. ISBN 978-92-9061-569-9 (NLM Classification: WM 290).
Paulino YC, Hurwitz EL, Warnakulasuriya S, et al. Screening for oral potentially malignant disorders among areca (betel) nut chewers in Guam and Saipan. BMC Oral Health. 2014;14(1):151. doi:10.1186/1472-6831-14-151.
Lord GA, Lim CK, Warnakulasuriya S, Peters TJ. Chemical and analytical aspects of areca nut. Addict Biol. 2002;7:99–102.
Nair J, Ohshima H, Nair UJ, Bartsch H. Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users. Crit Rev Toxicol. 1996;26(2):149–61.
Carossa S, Pera P, Doglio P, et al. Oral nitric oxide during plaque deposition. Eur J Clin Invest. 2001;31(10):876–9.
Nair U, Bartsch H, Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis. 2004;19(4):251–62.
Gupta PC, Warnakulasuriya S. Global epidemiology of areca nut usage. Addict Biol. 2002;7(1):77–83.
Garg A, Chaturvedi P, Gupta PC. A review of the systemic adverse effects of areca nut or betel nut. Indian J Med Paediatr Oncol. 2014;35(1):3–9.
Trivedy CR, Craig G, Warnakulasuriya S. The oral health consequences of chewing areca nut. Addict Biol. 2002;7(1):115–25.
Shiu MN, Chen TH, Chang SH, Hahn LJ. Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer. 2000;82(11):1871–4.
Hebbar PB, Sheshaprasad R, Gurudath S, Pai A, Sujatha D. Oral submucous fibrosis in India: are we progressing? Indian J Cancer. 2014;51(3):222–6.
Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW. Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med. 1994;23(2):65–9.
Kerr AR, Warnakulasuriya S, Mighell AJ, et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis. 2011;17 Suppl 1:42–57.
Mohammed F, Manohar V, Jose M, et al. Estimation of copper in saliva and areca nut products and its correlation with histological grades of oral submucous fibrosis. J Oral Pathol Med. 2014. doi:10.1111/jop.12222.
Trivedy C, Warnakulasuriya KA, Hazarey VK, Tavassoli M, Sommer P, Johnson NW. The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma. J Oral Pathol Med. 1999;28(6):246–51.
Dionne KR, Warnakulasuriya S, Binti Zain R, Cheong SC. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int J Cancer. 2015;136(3):503–15.
Thomas SJ, Bain CJ, Battistutta D, Ness AR, Paissat D, Maclennan R. Betel quid not containing tobacco and oral cancer: a report on a case-control study in Papua New Guinea and a meta-analysis of current evidence. Int J Cancer. 2007;120(6):1318–23.
Subapriya R, Thangavelu A, Mathavan B, Ramachandran CR, Nagini S. Assessment of risk factors for oral squamous cell carcinoma in Chidambaram, Southern India: a case-control study. Eur J Cancer Prev. 2007;16(3):251–6.
Guha N, Warnakulasuriya S, Vlaanderen J, Straif K. Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control. Int J Cancer. 2014;135(6):1433–43.
Gupta B, Johnson NW. Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One. 2014;9(11), e113385.
van Wyk CW, Stander I, Padayachee A, Grobler-Rabie AF. The areca nut chewing habit and oral squamous cell carcinoma in South African Indians. A retrospective study. S Afr Med J. 1993;83(6):425–9.
Gupta PC, Ray CS, Murti PR, Sinha DN. Rising incidence of oral cancer in Ahmedabad city. Indian J Cancer. 2014;51(Suppl):S67–72.
Petti S. Lifestyle risk factors for oral cancer. Oral Oncol. 2009;45(4-5):340–50.
Idris AM, Nair J, Friesen M, et al. Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan. Carcinogenesis. 1992;13(6):1001–5.
Nair J, Ohshima H, Friesen M, Croisy A, Bhide SV, Bartsch H. Tobacco-specific and betel nut-specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis. 1985;6(2):295–303.
Warnakulasuriya S, Sutherland G, Scully C. Tobacco, oral cancer, and treatment of dependence. Oral Oncol. 2005;41(3):244–60.
Xue J, Yang S, Seng S. Mechanisms of Cancer Induction by Tobacco-Specific NNK and NNN. Cancers (Basel). 2014;6(2):1138–56.
Datta S, Chaturvedi P, Mishra A, Pawar P. A review of Indian literature for association of smokeless tobacco with malignant and premalignant diseases of head and neck region. Indian J Cancer. 2014;51:200–8. Available from http://www.indianjcancer.com/text.asp?2014/51/3/200/146713. Accessed 14 Dec 2014.
National Cancer Institute and Centers for Disease Control and Prevention. Smokeless tobacco and public health: a global perspective. Bethesda, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Institutes of Health, National Cancer Institute; 2014. NIH Publication No. 14-7983. Available from http://nccd.cdc.gov/gtssdata/Ancillary/DownloadAttachment.aspx?ID=1201
Khan Z, Tonnies J, Muller S. Smokeless tobacco and oral cancer in South Asia: a systematic review with meta-analysis. J Cancer Epidemiol. 2014; Article ID 394696.
Alsanosy RM. Smokeless tobacco (shammah) in Saudi Arabia: a review of its pattern of use, prevalence, and potential role in oral cancer. Asian Pac J Cancer Prev. 2014;15(16):6477–83.
Idris AM, Ahmed HM, Malik MO. Toombak dipping and cancer of the oral cavity in the Sudan: a case-control study. Int J Cancer. 1995;63(4):477–80.
Nasher AT, Al-Hebshi NN, Al-Moayad EE, Suleiman AM. Viral infection and oral habits as risk factors for oral squamous cell carcinoma in Yemen: a case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118(5):566–72. e1.
Gartner C, Hall W. The potential role of snus in tobacco harm reduction. Addiction. 2009;104(9):1586–7.
Haddock CK, Weg MV, DeBon M, et al. Evidence that smokeless tobacco use is a gateway for smoking initiation in young adult males. Prev Med. 2001;32(3):262–7.
Critchley JA, Unal B. Health effects associated with smokeless tobacco: a systematic review. Thorax. 2003;58(5):435–43.
Kallischnigg G, Weitkunat R, Lee PN. Systematic review of the relation between smokeless tobacco and non-neoplastic oral diseases in Europe and the United States. BMC Oral Health. 2008;8:13.
IARC. Monographs on the evaluation of carcinogenic risk to humans, some traditional herbal medicines, some mycotoxins, naphthalene and styrene, vol. 82. Lyon: IARC Press; 2002. p. 171–4.
Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003;3(10):733–44.
International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risk to human, vol. 83. Lyon: IARC; 2004.
Zain RB. Cultural and dietary risk factors of oral cancer and precancer–a brief overview. Oral Oncol. 2001;37(3):205–10.
Madani AH, Dikshit M, Bhaduri D, Aghamolaei T, Moosavy SH, Azarpaykan A. Interaction of alcohol use and specific types of smoking on the development of oral cancer. Int J High Risk Behav Addict. 2014;3(1), e12120.
Shah JP, Johnson NW, Batsakis JG. Oral cancer. London/New York: Martin Dunitz/Thieme; 2003. Second edition in press, 2015.
Warnakulasuriya S, Dietrich T, Bornstein MM, et al. Oral health risks of tobacco use and effects of cessation. Int Dent J. 2010;60(1):7–30.
Marron M, Boffetta P, Zhang ZF, Zaridze D, Wünsch-Filho V, et al. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol. 2010;39(1):182–96.
Shiels MS, Gibson T, Sampson J, et al. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers. J Clin Oncol. 2014;32(35):3989–95.
WHO Framework Convention on Tobacco Control. Available from http://www.who.int/fctc/guidelines/en/. Accessed 18 Dec 2014.
Smith SE, Warnakulasuriya KA, Feyerabend C, Belcher M, Cooper DJ, Johnson NW. A smoking cessation programme conducted through dental practices in the UK. Br Dent J. 1998;185(6):299–303.
Jha P, Yurekli A, Ramasundarahettige C, Palipudi K, Zatonski W, Asma S, Gupta PC, Chaloupka FJ. Global tobacco control. In: DCP3, Vol. 6, Chapter 10. 2013. http://www.dcp-3.org/sites/default/files/chapters/DCP3,20Vol6/20Chap10/20Tobacco20/20JHA.pdf. Accessed 18 Dec 2014.
Whent H, Sayers M, Morgan A, Hunt R. Health update – alcohol. 2nd ed. London: Health Education Authority; 1997.
Rehm J. Alcohol consumption and mortality. What do we know and where should we go? Addiction. 2000;95(7):989–95.
Goldberg DM, Soleas GJ, Levesque M. Moderate alcohol consumption: the gentle face of Janus. Clin Biochem. 1999;32(7):505–18.
World Health Organisation. Status report on alcohol and health in 35 European countries. 2013. Available from http://www.euro.who.int/en/publications/abstracts/status-report-on-alcohol-and-health-in-35-european-countries-2013. Accessed 18 Dec 2014.
Nelson DE, Jarman DW, Rehm J, et al. Alcohol-attributable cancer deaths and years of potential life lost in the United States. Am J Public Health. 2013;103(4):641–8.
Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer. 2001;85(11):1700–5.
Farshadpour F, Kranenborg H, Calkoen EV, et al. Survival analysis of head and neck squamous cell carcinoma: influence of smoking and drinking. Head Neck. 2011;33(6):817–23.
World Health Organization, Department of Mental Health and Substance Abuse. Global status report on alcohol 2004. Geneva: WHO; 2004.
Institute National Du Cancer. Alcohol and risk of cancer: current status of scientific data and recommendations for public health. 2007. Available from http://www.e-cancer.fr/la-sante-publique/prevention/alcoolisme. Accessed 26 Jan 2010.
World Health Organization. Evidence for the effectiveness and cost-effectiveness of interventions to reduce alcohol-related harm. Available from http://www.euro.who.int/document/E92823.pdf. Accessed 28 Jan 2010.
National Health and Medical Research Council. Australian guidelines to reduce health risk from drinking alcohol. Available from http://www.nhmrc.gov.au/_files_nhmrc/file/publications/synopses/ds10-alcohol.pdf. Accessed 18 Dec 2014.
Tsai ST, Wong TY, Ou CY, et al. The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer. Int J Cancer. 2014;135(10):2424–36.
Ogden GR, Wight AJ. Aetiology of oral cancer: alcohol. Br J Oral Maxillofac Surg. 1998;36(4):247–51.
Howie NM, Trigkas TK, Cruchley AT, Wertz PW, Squier CA, Williams DM. Short-term exposure to alcohol increases the permeability of human oral mucosa. Oral Dis. 2001;7(6):349–54.
De Stefani E, Boffetta P, Oreggia F, Fierro L, Mendilaharsu M. Hard liquor drinking is associated with higher risk of cancer of the oral cavity and pharynx than wine drinking. A case-control study in Uruguay. Oral Oncol. 1998;34(2):99–104.
Altieri A, Bosetti C, Gallus S, et al. Wine, beer and spirits and risk of oral and pharyngeal cancer: a case-control study from Italy and Switzerland. Oral Oncol. 2004;40(9):904–9.
Maasland DH, van den Brandt PA, Kremer B, Goldbohm RA, Schouten LJ. Alcohol consumption, cigarette smoking and the risk of subtypes of head-neck cancer: results from the Netherlands Cohort Study. BMC Cancer. 2014;14:187.
Druesne-Pecollo N, Keita Y, Touvier M, et al. Alcohol drinking and second primary cancer risk in patients with upper aerodigestive tract cancers: a systematic review and meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev. 2013;23(2):324–31.
Petti S, Masood M, Messano GA, Scully C. Alcohol is not a risk factor for oral cancer in nonsmoking, betel quid non-chewing individuals. A meta-analysis update. Ann Ig. 2013;25(1):3–14.
Elmore JG, Horwitz RI. Oral cancer and mouthwash use: evaluation of the epidemiologic evidence. Otolaryngol Head Neck Surg. 1995;113(3):253–61.
McCullough MJ, Farah CS. The role of alcohol in oral carcinogenesis with particular reference to alcohol-containing mouthwashes. Aust Dent J. 2009;53:302–5.
Guha N, Boffetta P, Wunsch Filho V, et al. Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am J Epidemiol. 2007;166(10):1159–73.
Young TB, Ford CN, Brandenburg JH. An epidemiologic study of oral cancer in a statewide network. Am J Otolaryngol. 1986;7(3):200–8.
Winn DM, Diehl SR, Brown LM, et al. Mouthwash in the etiology of oral cancer in Puerto Rico. Cancer Causes Control. 2001;12(5):419–29.
La Vecchia C. Mouthwash and oral cancer risk: an update. Oral Oncol. 2009;45(3):198–200.
Warnakulasuriya S. Causes of oral cancer–an appraisal of controversies. Br Dent J. 2009;207(10):471–5.
Gandini S, Negri E, Boffetta P, La Vecchia C, Boyle P. Mouthwash and oral cancer risk quantitative meta-analysis of epidemiologic studies. Ann Agric Environ Med. 2012;19(2):173–80. See also Currie S, Farah CS. Alcohol-containing mouthwash and oral cancer risk: a review of current evidence. OA Alcohol 2014 Feb 10;2(1):4.
Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48(11):3282–7.
Petti S, Masood M, Scully C. The magnitude of tobacco smoking-betel quid chewing-alcohol drinking interaction effect on oral cancer in South-East Asia. A meta-analysis of observational studies. PLoS One. 2013;8(11), e78999. doi:10.1371/journal.pone.0078999. eCollection 2013.
Amarasinghe HK, Johnson NW, Lalloo R, Kumaraarachchi M, Warnakulasuriya S. Derivation and validation of a risk-factor model for detection of oral potentially malignant disorders in populations with high prevalence. Br J Cancer. 2010;103(3):303–9.
Jegu J, Binder-Foucard F, Borel C, Velten M. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer. Oral Oncol. 2013;49(1):9–14.
Xu CC, Biron VL, Puttagunta L, Seikaly H. HPV status and second primary tumours in oropharyngeal squamous cell carcinoma. J Otolaryngol Head Neck Surg. 2013;42:36.
Jain KS, Sikora AG, Baxi SS, Morris LG. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer. Cancer. 2013;119(10):1832–7.
Stewart BW, Kleihues P, Stewart Bernard W, Paul K. The causes of cancer. In: World cancer report. Lyon: IARC Press; 2003. p. 22–31.
World Health Organization. Cancer: diet and physical activity’s impact. Available from www.who.int/dietphysicalactivity/publications/facts/cancer/en. Accessed 2 Dec 2014.
De Stefani E, Boffetta P, Ronco AL, et al. Dietary patterns and risk of cancer of the oral cavity and pharynx in Uruguay. Nutr Cancer. 2005;51(2):132–9.
De Stefani E, Oreggia F, Boffetta P, Deneo-Pellegrini H, Ronco A, Mendilaharsu M. Tomatoes, tomato-rich foods, lycopene and cancer of the upper aerodigestive tract: a case-control in Uruguay. Oral Oncol. 2000;36(1):47–53.
Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol. 2004;40(3):304–13.
Garavello W, Lucenteforte E, Bosetti C, et al. Diet diversity and the risk of laryngeal cancer: a case-control study from Italy and Switzerland. Oral Oncol. 2009;45(1):85–9.
Lucenteforte E, Garavello W, Bosetti C, La Vecchia C. Dietary factors and oral and pharyngeal cancer risk. Oral Oncol. 2009;45(6):461–7.
Garavello W, Lucenteforte E, Bosetti C, La Vecchia C. The role of foods and nutrients on oral and pharyngeal cancer risk. Minerva Stomatol. 2009;58(1–2):25–34.
Levi F, Pasche C, La Vecchia C, Lucchini F, Franceschi S, Monnier P. Food groups and risk of oral and pharyngeal cancer. Int J Cancer. 1998;77(5):705–9.
Bravi F, Bosetti C, Filomeno M, et al. Foods, nutrients and the risk of oral and pharyngeal cancer. Br J Cancer. 2013;109(11):2904–10.
Filomeno M, Bosetti C, Garavello W, et al. The role of a Mediterranean diet on the risk of oral and pharyngeal cancer. Br J Cancer. 2014;111(5):981–6.
Etemadi A, O’Doherty MG, Freedman ND, Hollenbeck AR, Dawsey SM, Abnet CC. A prospective cohort study of body size and risk of head and neck cancers in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2422–9.
Schwartz J, Shklar G. Regression of experimental oral carcinomas by local injection of beta-carotene and canthaxanthin. Nutr Cancer. 1988;11(1):35–40.
Shklar G, Schwartz JL, Trickler DP, Reid S. Prevention of experimental cancer and immunostimulation by vitamin E (immunosurveillance). J Oral Pathol Med. 1990;19(2):60–4.
Schwartz JL, Shklar G, Flynn E, Trickler D. The administration of beta carotene to prevent and regress oral carcinoma in the hamster cheek pouch and the associated enhancement of the immune response. Adv Exp Med Biol. 1990;262:77–93.
Warnakulasuriya S. Food, nutrition and oral cancer. In: Wilson M, editor. Food constituents and oral health. Oxford: Woodhead Publishing; 2009. p. 273–95.
Pavia M, Pileggi C, Nobile CG, Angelillo IF. Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. Am J Clin Nutr. 2006;83(5):1126–34.
Nagao T, Ikeda N, Warnakulasuriya S, et al. Serum antioxidant micronutrients and the risk of oral leukoplakia among Japanese. Oral Oncol. 2000;36(5):466–70.
Amarasinghe HK, Usgodaarachchi U, Kumaraarachchi M, Johnson NW, Warnakulasuriya S. Diet and risk of oral potentially malignant disorders in rural Sri Lanka. J Oral Pathol Med. 2013;42(9):656–62.
Sankaranarayanan R, Mathew B, Varghese C, et al. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment. Oral Oncol. 1997;33(4):231–6.
Papadimitrakopoulou VA, Lee JJ, William Jr WN, et al. Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy. J Clin Oncol. 2009;27(4):599–604.
Galeone C, Edefonti V, Parpinel M, et al. Folate intake and the risk of oral cavity and pharyngeal cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology Consortium. Int J Cancer. 2015;136(4):904–14.
Tsao AS, Liu D, Martin J, et al. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila Pa). 2009;2(11):931–41.
Wang W, Yang Y, Zhang W, Wu W. Association of tea consumption and the risk of oral cancer: a meta-analysis. Oral Oncol. 2014;50(4):276–81.
Martin L, de van der Schueren MA, Blauwhoff-Buskermolen S, Baracos V, Gramlich L. Identifying the barriers and enablers to nutrition care in head and neck and esophageal cancers: an international qualitative study. JPEN J Parenter Enteral Nutr. 2014. pii: 0148607114552847. [Epub ahead of print].
Tai J, Yang M, Ni X, et al. Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population. Cancer Genet Cytogenet. 2010;196(1):76–82.
Choudhury JH, Ghosh SK. Gene-environment interaction and susceptibility in head and neck cancer patients and in their first-degree relatives: a study of Northeast Indian population. J Oral Pathol Med. 2014. doi:10.1111/jop.12249. [Epub ahead of print].
Handley TP, McCaul JA, Ogden GR. Dyskeratosis congenita. Oral Oncol. 2006;42(4):331–6.
De Pasquale K, Sataloff RT. Candida of the larynx. Ear Nose Throat J. 2003;82(6):419.
Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42(5):461–74.
Alnuaimi AD, Wiesenfeld D, O’Brien-Simpson NM, Reynolds EC, McCullough MJ. Oral Candida colonization in oral cancer patients and its relationship with traditional risk factors of oral cancer: a matched case-control study. Oral Oncol. 2014. pii: S1368-8375(14)00347-9. doi:10.1016/j.oraloncology.2014.11.008. [Epub ahead of print].
Stringer AM, Logan RM. The role of oral flora in the development of chemotherapy-induced oral mucositis. J Oral Pathol Med. 2014. doi:10.1111/jop.12152. [Epub ahead of print].
Schmidt BL, Kuczynski J, Bhattacharya A, et al. Changes in abundance of oral microbiota associated with oral cancer. PLoS One 2014;9(6):e98741. doi:10.1371/journal.pone.0098741. eCollection 2014.
D’Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944–56.
Andrews E, Seaman WT, Webster-Cyriaque J. Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV. Oral Oncol. 2009;45(6):486–91.
Mirghani H, Amen F, Moreau F, Lacau St Guily J. Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma? S1368-8375(14)00350-9 [pii]. doi:10.1016/j.oraloncology.2014.11.011.
Ndiaye C, Mena M, Alemany L, et al. HPV DNA, E6/E7 mRNA, and p16(INK4a) detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319–31.
Gan LL, Zhang H, Guo JH, Fan MW. Prevalence of human papillomavirus infection in oral squamous cell carcinoma: a case-control study in Wuhan. China Asian Pac J Cancer Prev. 2014;15(14):5861–5.
Dahlstrom KR, Burchell AN, Ramanakumar AV, et al. Sexual transmission of oral human papillomavirus infection among men. Cancer Epidemiol Biomarkers Prev. 2014;23(12):2959–64.
Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol. 2013;50(5):380–6.
Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009–2010. JAMA 2012;307(7):693–703. See also Sanders AE, Slade GD, Patton LL. National prevalence of oral HPV infection and related risk factors in the U.S. adult population. Oral Dis. 2012 Jul;18(5):430–41. doi:10.1111/j.1601-0825.2011.01892.x. Epub 2012 Jan 18. Review, and D'Souza G, Gross ND, Pai SI, Haddad R, et al. Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners J Clin Oncol. 2014 Aug 10;32(23):2408–15. doi:10.1200/JCO.2014.55.1341. Epub 2014 Apr 28.
Cook RL, Thompson EL, Kelso NE, et al. Sexual behaviors and other risk factors for oral human papillomavirus infections in young women. Sex Transm Dis. 2014;41(8):486–92.
Peck BW, Dahlstrom KR, Gan SJ, et al. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck. 2013;35(6):794–9.
Acharya S, Ekalaksananan T, Vatanasapt P, et al. Association of Epstein-Barr virus infection with oral squamous cell carcinoma in a case-control study. J Oral Pathol Med. 2014. doi:10.1111/jop.12231.
Zheng TZ, Boyle P, Hu HF, et al. Dentition, oral hygiene, and risk of oral cancer: a case-control study in Beijing, People’s Republic of China. Cancer Causes Control. 1990;1(3):235–41.
Rotundo LD, Toporcov TN, Biazevic GH, de Carvalho MB, Kowalski LP, Antunes JL. Are recurrent denture-related sores associated with the risk of oral cancer? A case control study. Rev Bras Epidemiol. 2013;16(3):705–15.
Perry BJ, Zammit AP, Lewandowski AW, et al. Sites of origin of oral cavity cancer in nonsmokers vs smokers: possible evidence of dental trauma carcinogenesis and its importance compared with human papillomavirus. JAMA Otolaryngol Head Neck Surg. 2014. doi:10.1001/jamaoto.2014.2620. [Epub ahead of print].
Yao QW, Zhou DS, Peng HJ, Ji P, Liu DS. Association of periodontal disease with oral cancer: a meta-analysis. Tumour Biol. 2014;35(7):7073–7.
Zeng XT, Deng AP, Li C, Xia LY, Niu YM, Leng WD. Periodontal disease and risk of head and neck cancer: a meta-analysis of observational studies. PLoS One. 2014;8(10), e79017.
Ahrens W, Pohlabeln H, Foraita R, et al. Oral health, dental care and mouthwash associated with upper aerodigestive tract cancer risk in Europe: the ARCAGE study. Oral Oncol. 2014;50(6):616–25.
Wake M. The urban/rural divide in head and neck cancer–the effect of atmospheric pollution. Clin Otolaryngol Allied Sci. 1993;18(4):298–302.
Sapkota A, Gajalakshmi V, Jetly DH, et al. Indoor air pollution from solid fuels and risk of hypopharyngeal/laryngeal and lung cancers: a multicentric case-control study from India. Int J Epidemiol. 2008;37(2):321–8.
Dietz A, Senneweld E, Maier H. Indoor air pollution by emissions of fossil fuel single stoves: possibly a hitherto underrated risk factor in the development of carcinomas in the head and neck. Otolaryngol Head Neck Surg. 1995;112(2):308–15.
International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, Indoor air pollution from heating and cooking: some solid fuels and cooking oil fumes, vol. 95. Lyon: IARC Press; 2006.
Franco EL, Kowalski LP, Oliveira BV, et al. Risk factors for oral cancer in Brazil: a case-control study. Int J Cancer. 1989;43(6):992–1000.
Zheng YM, Tuppin P, Hubert A, et al. Environmental and dietary risk factors for nasopharyngeal carcinoma: a case-control study in Zangwu County, Guangxi, China. Br J Cancer. 1994;69(3):508–14.
Pintos J, Franco EL, Kowalski LP, Oliveira BV, Curado MP. Use of wood stoves and risk of cancers of the upper aero-digestive tract: a case-control study. Int J Epidemiol. 1998;27(6):936–40.
Baker SR, Krause CJ. Carcinoma of the lip. Laryngoscope. 1980;90(1):19–27.
Pukkala E, Notkola V. Cancer incidence among Finnish farmers, 1979–93. Cancer Causes Control. 1997;8(1):25–33.
Wiklund K, Dich J. Cancer risks among male farmers in Sweden. Eur J Cancer Prev. 1995;4(1):81–90.
Antoniades DZ, Styanidis K, Papanayotou P, Trigonidis G. Squamous cell carcinoma of the lips in a northern Greek population. Evaluation of prognostic factors on 5-year survival rate–I. Eur J Cancer B Oral Oncol. 1995;31B(5):333–9.
Pukkala E, Soderholm AL, Lindqvist C. Cancers of the lip and oropharynx in different social and occupational groups in Finland. Eur J Cancer B Oral Oncol. 1994;30B(3):209–15.
Pogoda JM, Preston-Martin S. Solar radiation, lip protection, and lip cancer risk in Los Angeles County women (California, United States). Cancer Causes Control. 1996;7(4):458–63.
Levi F, La Vecchia C, Te VC, Franceschi S. Trends in lip cancer incidence in Vaud, Switzerland. Br J Cancer. 1993;68(5):1012–3.
Alho OP, Keranen MR, Kantola S, et al. Lip cancer in Northern Finland: changing incidence and clinical characteristics. J Oral Pathol Med. 2000;29(7):299–302.
Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10):575–80.
van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45(4–5):317–23.
Napier SS, Cowan CG, Gregg TA, Stevenson M, Lamey PJ, Toner PG. Potentially malignant oral lesions in Northern Ireland: size (extent) matters. Oral Dis. 2003;9(3):129–37.
Chung CH, Yang YH, Wang TY, Shieh TY, Warnakulasuriya S. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J Oral Pathol Med. 2005;34(8):460–6.
Thomas SJ, Harris R, Ness AR, et al. Betel quid not containing tobacco and oral leukoplakia: a report on a cross-sectional study in Papua New Guinea and a meta-analysis of current evidence. Int J Cancer. 2008;123(8):1871–6.
Scheifele C, Reichart PA, Dietrich T. Low prevalence of oral leukoplakia in a representative sample of the US population. Oral Oncol. 2003;39(6):619–25.
Ministry of Health Sri Lanka. National Oral Health Survey, Sri Lanka (2002/2003). Colombo. 3rd publication 2009.
Garcia-Pola Vallejo MJ, Martinez Diaz-Canel AI, Garcia Martin JM, Gonzalez Garcia M. Risk factors for oral soft tissue lesions in an adult Spanish population. Community Dent Oral Epidemiol. 2002;30(4):277–85.
Reichart PA. Oral mucosal lesions in a representative cross-sectional study of aging Germans. Community Dent Oral Epidemiol. 2000;28(5):390–8.
Nagao T, Ikeda N, Fukano H, Miyazaki H, Yano M, Warnakulasuriya S. Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncol. 2000;36(4):340–6.
Zain RB, Ikeda N, Razak IA, et al. A national epidemiological survey of oral mucosal lesions in Malaysia. Community Dent Oral Epidemiol. 1997;25(5):377–83.
Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Prevalence study of oral white lesions with special reference to a new definition of oral leucoplakia. Eur J Cancer B Oral Oncol. 1996;32B(6):416–9.
Banoczy J, Rigo O. Prevalence study of oral precancerous lesions within a complex screening system in Hungary. Community Dent Oral Epidemiol. 1991;19(5):265–7.
Ikeda N, Ishii T, Iida S, Kawai T. Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population. Community Dent Oral Epidemiol. 1991;19(3):160–3.
Axell T, Rundquist L. Oral lichen planus – a demographic study. Community Dent Oral Epidemiol. 1987;15:52–6.
Axell T. Occurrence of leukoplakia and some other oral white lesions among 20,333 adult Swedish people. Community Dent Oral Epidemiol. 1987;15(1):46–51.
Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39(8):770–80.
Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37(1):1–10.
Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14(1):47–62.
Pindborg JJ, Mehta FS, Daftary DK. Incidence of oral cancer among 30,000 villagers in India in a 7-year follow-up study of oral precancerous lesions. Community Dent Oral Epidemiol. 1975;3(2):86–8.
Silverman Jr S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer. 1984;53(3):563–8.
Warnakulasuriya S, Kovacevic T, Madden P, et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med. 2011;40(9):677–83.
Sperandio M, Brown AL, Lock C, et al. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders. Cancer Prev Res (Phila). 2013;6(8):822–31.
Liu W, Shi LJ, Wu L, et al. Oral cancer development in patients with leukoplakia–clinicopathological factors affecting outcome. PLoS One. 2012;7(4), e34773.
Ho MW, Risk JM, Woolgar JA, et al. The clinical determinants of malignant transformation in oral epithelial dysplasia. Oral Oncol. 2012;48(10):969–76.
Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc. 2014;145(1):45–56.
Brouns E, Baart J, Karagozoglu K, Aartman I, Bloemena E, van der Waal I. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. Oral Dis. 2014;20(3):e19–24.
Bouquot JE, Kurland LT, Weiland LH. Laryngeal keratosis and carcinoma in the Rochester, MN, population 1935–1984. Cancer Detect Prev. 1991;15(2):83–91.
Gale N, Michaels L, Luzar B, et al. Current review on squamous intraepithelial lesions of the larynx. Histopathology. 2009;54(6):639–56.
Vaezi MF, Qadeer MA, Lopez R, Colabianchi N. Laryngeal cancer and gastroesophageal reflux disease: a case-control study. Am J Med. 2006;119(9):768–76.
Bosatra A, Bussani R, Silvestri F. From epithelial dysplasia to squamous carcinoma in the head and neck region: an epidemiological assessment. Acta Otolaryngol Suppl. 1997;527:47–8.
Gallus S, Bosetti C, Franceschi S, Levi F, Negri E, La Vecchia C. Laryngeal cancer in women: tobacco, alcohol, nutritional, and hormonal factors. Cancer Epidemiol Biomarkers Prev. 2003;12(6):514–7.
Fiorella R, Di Nicola V, Resta L. Epidemiological and clinical relief on hyperplastic lesions of the larynx. Acta Otolaryngol Suppl. 1997;527:77–81.
Maier H, Tisch M. Epidemiology of laryngeal cancer: results of the Heidelberg case-control study. Acta Otolaryngol Suppl. 1997;527:160–4.
Parnes SM. Asbestos and cancer of the larynx: is there a relationship? Laryngoscope. 1990;100(3):254–61.
Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006;31(4):259–66.
Lewin JS, Gillenwater AM, Garrett JD, et al. Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx. Cancer. 2003;97(4):1010–4.
Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization classification of tumors: pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p. 221–4.
Ellis GL, Auclair PL, Gnepp DR, editors. Surgical pathology of the salivary glands. Philadelphia, PA: WB Saunders; 1991.
Eisele DW, Johns ME. Salivary gland neoplasms. In: Bailey BJ, editor. Head and neck surgery-otolaryngology. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. p. 1279–97.
Kessler A, Handler SD. Salivary gland neoplasms in children: a 10-year survey at the Children’s Hospital of Philadelphia. Int J Pediatr Otorhinolaryngol. 1994;29(3):195–202.
Lack EE, Upton MP. Histopathologic review of salivary gland tumors in childhood. Arch Otolaryngol Head Neck Surg. 1988;114(8):898–906.
Seifert G, Okabe H, Caselitz J. Epithelial salivary gland tumors in children and adolescents. Analysis of 80 cases (Salivary Gland Register 1965–1984). ORL J Otorhinolaryngol Relat Spec. 1986;48(3):137–49.
Shikhani AH, Johns ME. Tumors of the major salivary glands in children. Head Neck Surg. 1988;10(4):257–63.
Saw D, Lau WH, Ho JH, Chan JK, Ng CS. Malignant lymphoepithelial lesion of the salivary gland. Hum Pathol. 1986;17(9):914–23.
Tsai CC, Chen CL, Hsu HC. Expression of Epstein-Barr virus in carcinomas of major salivary glands: a strong association with lymphoepithelioma-like carcinoma. Hum Pathol. 1996;27(3):258–62.
Iezzoni JC, Gaffey MJ, Weiss LM. The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas. Am J Clin Pathol. 1995;103(3):308–15.
Hamilton-Dutoit SJ, Therkildsen MH, Neilsen NH, Jensen H, Hansen JP, Pallesen G. Undifferentiated carcinoma of the salivary gland in Greenlandic Eskimos: demonstration of Epstein-Barr virus DNA by in situ nucleic acid hybridization. Hum Pathol. 1991;22(8):811–5.
Martinelli M, Martini F, Rinaldi E, et al. Simian virus 40 sequences and expression of the viral large T antigen oncoprotein in human pleomorphic adenomas of parotid glands. Am J Pathol. 2002;161(4):1127–33.
Belsky JL, Tachikawa K, Cihak RW, Yamamoto T. Salivary gland tumors in atomic bomb survivors, Hiroshima-Nagasaki, 1957 to 1970. JAMA. 1972;219(7):864–8.
Belsky JL, Takeichi N, Yamamoto T, et al. Salivary gland neoplasms following atomic radiation: additional cases and reanalysis of combined data in a fixed population, 1957–1970. Cancer. 1975;35(2):555–9.
Saku T, Hayashi Y, Takahara O, et al. Salivary gland tumors among atomic bomb survivors, 1950–1987. Cancer. 1997;79(8):1465–75.
Mihailescu D, Shore-Freedman E, Mukani S, Lubin J, Ron E, Schneider AB. Multiple neoplasms in an irradiated cohort: pattern of occurrence and relationship to thyroid cancer outcome. J Clin Endocrinol Metab. 2002;87(7):3236–41.
Modan B, Chetrit A, Alfandary E, et al. Increased risk of salivary gland tumors after low-dose irradiation. Laryngoscope. 1998;108(7):1095–7.
Hoffman DA, McConahey WM, Fraumeni Jr JF, Kurland LT. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol. 1982;11(3):218–24.
Preston-Martin S, Thomas DC, White SC, Cohen D. Prior exposure to medical and dental x-rays related to tumors of the parotid gland. J Natl Cancer Inst. 1988;80(12):943–9.
Preston-Martin S, White SC. Brain and salivary gland tumors related to prior dental radiography: implications for current practice. J Am Dent Assoc. 1990;120(2):151–8.
Nagler RM, Laufer D. Tumors of the major and minor salivary glands: review of 25 years of experience. Anticancer Res. 1997;17(1B):701–7.
Spitz MR, Sider JG, Newell GR. Salivary gland cancer and risk of subsequent skin cancer. Head Neck. 1990;12(3):254–6.
Spitz MR, Sider JG, Newell GR, Batsakis JG. Incidence of salivary gland cancer in the United States relative to ultraviolet radiation exposure. Head Neck Surg. 1988;10(5):305–8.
Miller AS, Harwick RD, Alfaro-Miranda M, Sundararajan M. Search for correlation of radon levels and incidence of salivary gland tumors. Oral Surg Oral Med Oral Pathol. 1993;75(1):58–63.
Auvinen A, Hietanen M, Luukkonen R, Koskela RS. Brain tumors and salivary gland cancers among cellular telephone users. Epidemiology. 2002;13(3):356–9.
Johansen C, Boice Jr J, McLaughlin J, Olsen J. Cellular telephones and cancer–a nationwide cohort study in Denmark. J Natl Cancer Inst. 2001;93(3):203–7.
Horn-Ross PL, Ljung BM, Morrow M. Environmental factors and the risk of salivary gland cancer. Epidemiology. 1997;8(4):414–9.
Milham Jr S. Cancer mortality pattern associated with exposure to metals. Ann N Y Acad Sci. 1976;271:243–9.
Swanson GM, Belle SH. Cancer morbidity among woodworkers in the U.S. automotive industry. J Occup Med. 1982;24(4):315–9.
Swanson GM, Burns PB. Cancer incidence among women in the workplace: a study of the association between occupation and industry and 11 cancer sites. J Occup Environ Med. 1995;37(3):282–7.
Swanson GM, Burns PB. Cancers of the salivary gland: workplace risks among women and men. Ann Epidemiol. 1997;7(6):369–74.
Graham S, Blanchet M, Rohrer T. Cancer in asbestos-mining and other areas of Quebec. J Natl Cancer Inst. 1977;59(4):1139–45.
Muscat JE, Wynder EL. A case/control study of risk factors for major salivary gland cancer. Otolaryngol Head Neck Surg. 1998;118(2):195–8.
Zheng W, Shu XO, Ji BT, Gao YT. Diet and other risk factors for cancer of the salivary glands: a population-based case-control study. Int J Cancer. 1996;67(2):194–8.
Dietz A, Barme B, Gewelke U, Sennewald E, Heller WD, Maier H. The epidemiology of parotid tumors. A case control study. HNO. 1993;41(2):83–90.
Horn-Ross PL, Morrow M, Ljung BM. Diet and the risk of salivary gland cancer. Am J Epidemiol. 1997;146(2):171–6.
Jeannon JP, Soames JV, Bell H, Wilson JA. Immunohistochemical detection of oestrogen and progesterone receptors in salivary tumours. Clin Otolaryngol Allied Sci. 1999;24(1):52–4.
Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol. 2003;119(6):801–6.
Fan CY, Melhem MF, Hosal AS, Grandis JR, Barnes EL. Expression of androgen receptor, epidermal growth factor receptor, and transforming growth factor alpha in salivary duct carcinoma. Arch Otolaryngol Head Neck Surg. 2001;127(9):1075–9.
Chang YM, Barrett JH, Bishop DT, et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol. 2009;38(3):814–30.
Meleti M, Leemans CR, Mooi WJ, Vescovi P, van der Waal I. Oral malignant melanoma: a review of the literature. Oral Oncol. 2007;43(2):116–21.
Sasco AJ, Jaquet A, Boidin E, et al. The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One. 2010;5(1), e8621.
Otoh EC, Johnson NW, Mandong BM, Danfillo IS. Primary head and neck cancers in Jos, Nigeria: a re-visit. West Afr J Med. 2006;25(2):92–100.
Webster-Cyriaque J, Duus K, Cooper C, Duncan M. Oral EBV and KSHV infection in HIV. Adv Dent Res. 2006;19(1):91–5.
Speicher D, Johnson NW. Improving the detection of human herpesvirus-8 in AIDS patients. In: Rahmatulla M, Shah N, editors. Research priorities for meeting oral health goals in developing countries. Hyderabad: International Association for Dental Research/Indian Academy for Advanced Dental Education/Paras Medical Books; 2009. p. 66–79.
Wright JM, Odell EW, Speight PM, Takata T. Odontogenic tumors, WHO 2005: where do we go from here? Head Neck Pathol. 2014;8(4):373–82.
Daley TD, Wysocki GP, Pringle GA. Relative incidence of odontogenic tumors and oral and jaw cysts in a Canadian population. Oral Surg Oral Med Oral Pathol. 1994;77(3):276–80.
Jing W, Xuan M, Lin Y, et al. Odontogenic tumours: a retrospective study of 1642 cases in a Chinese population. Int J Oral Maxillofac Surg. 2007;36(1):20–5.
Buchner A, Merrell PW, Carpenter WM. Relative frequency of central odontogenic tumors: a study of 1,088 cases from Northern California and comparison to studies from other parts of the world. J Oral Maxillofac Surg. 2006;64(9):1343–52.
Smith C. Odontogenic neoplasms and hamartomas. Chapter 33. In: Prabhu R, Wilson DF, Daftary DK, Johnson NW, editors. Oral diseases in the tropics. Oxford: Oxford University Press; 1992.
Ladeinde AL, Ajayi OF, Ogunlewe MO, et al. Odontogenic tumors: a review of 319 cases in a Nigerian teaching hospital. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(2):191–5.
Ogunlewe MO, Ajayi OF, Adeyemo WL, Ladeinde AL, James O. Osteogenic sarcoma of the jaw bones: a single institution experience over a 21-year period. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(1):76–81.
Fernandes R, Nikitakis NG, Pazoki A, Ord RA. Osteogenic sarcoma of the jaw: a 10-year experience. J Oral Maxillofac Surg. 2007;65(7):1286–91.
Premalatha BR, Patil S, Rao RS, Reddy NP, Indu M. Odontogenic tumor markers – an overview. J Int Oral Health. 2013;5(2):59–69.
Gomes CC, Diniz MG, Gomez RS. Progress towards personalized medicine for ameloblastoma. J Pathol. 2014;232(5):488–91.
Richardson MS, Muller S. Malignant odontogenic tumors: an update on selected tumors. Head Neck Pathol. 2014;8(4):411–20.
Hirshberg A, Shnaiderman-Shapiro A, Kaplan I, Berger R. Metastatic tumours to the oral cavity – pathogenesis and analysis of 673 cases. Oral Oncol. 2008;44(8):743–52.
Hirshberg A, Buchner A. Metastatic tumours to the oral region. An overview. Eur J Cancer B Oral Oncol. 1995;31B(6):355–60.
Hobdell MH, Oliveira ER, Bautista R, et al. Oral diseases and socio-economic status (SES). Br Dent J. 2003;194(2):91–6. discussion 88.
Lee JY, Divaris K. The ethical imperative of addressing oral health disparities: a unifying framework. J Dent Res. 2014;93(3):224–30.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Johnson, N.W., Amarasinghe, H.K. (2016). Epidemiology and Aetiology of Head and Neck Cancers. In: Bernier, J. (eds) Head and Neck Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-27601-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-27601-4_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27599-4
Online ISBN: 978-3-319-27601-4
eBook Packages: MedicineMedicine (R0)